SlideShare a Scribd company logo
TOPIC: NEAR FATAL CASE OF
AMLODIPINE POISONING IN AN INFANT
INDIAN JOURNAL OF PEDIATRICS
JUNE 2013 volume 80 by Somashekar M. Nimbalkar ,Dipen
vasudev patel
INTRODUCTION
• Infants contribute about 5.25% of poisoning
exposure. Only one case of
amlodipine poisoning is reported in infants and
the child recovered after treatment.
• The authors report an 11 month old infant with
nearly fatal amlodipine poisoning.
CASE REPORT
• A 11 month old infant received 6 doses of 15mg of
amlodipine which was dispensed against
prescribed amoxicillin for lower respiratory tract
infection.
• He presented with vomitting and reduced activity.
• He worsened over few hours with increased
lethargy, bradychardia, respiratory distress and
progressive loss of consiousness , irregular heart
sounds, bilateral creptations over chest and
hepatomegaly.
• His blood sugar was 382mg/dl.
• On admission he had anemia.
• Blood pressure remained at 70/40 mm Hg
• He was progressed to hypotensive shock within
three hours of admission.
INVESTIGATION ADMISSION 24HOURS 48 HOURS 72 HOURS
s.Creatinine(mg/dl)
(0.6-1.5mg/dl)
0.59 0.81 0.49 0.34
s.Urea(8-25mg/dl) - 108 56 8
s.Sodium
(135-148mmol/l)
129 124 131 146
s.Potassium
(3.5-5.5 mmol/l)
5.8 5.7 3.6 21.9
s.Calcium(8-11mg/dl) 9.34 10.6 11.05 -
INVESTIGATION ADMISSION 24 HRS 48 HRS 72 HRS
Alanine transaminase
(u/l)
44 - - 124
Aspartate
transaminase(u/l)
112 - - 622
s.Total bilirubin(mg/dl) 0.24 - - 0.49
Haemoglobin(g/dl) 8.2 9.7 -
HCO3(22-29 meq/l) 17 19.3 23.6 -
PCO2(41-51mm hg) 33.4 34.6 34.6 -
PO2(30-40 mm hg) 267 356.1 398.6 -
• His blood sugar was found increased because
Calcium channel blockers bind to alpha unit of L-
type channel results in impaired secretion of
insulin results in hyperglycemia.
• CCB poisoning also results in insulin resistance.
• The maximum therapeutic dose of amlodipine is
0.6mg/kg per day. But the 6kg infant received 15
mg three times a day.
• Amlodipine three times a day for two days (about
12.5 times maximum dose of amlodipine).
TREATMENT
• He received mechanical ventilation.
• Fluid therapy with normal saline was given.
• His parameters only improved after giving insulin
0.5-1 unit/kg/hr was given for (15 hours) along with
calcium gluconate infusion for (72 hours).
• He was treated with adrenaline which is a powerful
cardiac stimulant .It acts on beta receptors and
increases heart rate, cardiac output.(as CCB in
higher dose causes decrease in heart rate,
decrease cardiac output)
• Calcium channel blockers usually causes negative
ionotropic effect ( weaken heart contraction and
slows the heart rate).
• So positive ionotropes such as dopamine,
epinephrine are given to change the force of heart
contractions and improves the heart rate.
• To manage renal failure , oliguria(decrease in urine
output), pulmonary edema, congestive cardiac
failure peritoneal dialysis was initiated at 24 hours
of admission and continued for 48 hours.
 Child improved hence insulin infusion was tapered
and stopped after 15 hours.
 Ionotropes was tapered after 48 hours.
 Calcium gluconate stopped after 72 hours.
 Liver enzymes increased after 72 hours of ingestion
without develpoment of jaundice.
 Patient was discharged after 10 days .
DISCUSSION
• Calcium channel blockers are a potential source of
risk for children due to the high dosage from
strength ,in relation to the body weight.
• A single dose of 10 mg nifedipine tablet was
associated with the death of an infant.
• Amlodipine has large volume of distribution and
half life is 35-45 hours and overdose causes
prolonged calcium channel blockers toxicity.
• Animal studies have shown insulin improves
myocardial infraction during shock induced by
calcium channel blockers toxicity.
• The author’s says that insulin therapy can be
recommended as first line therapy for calcium
channel blockers toxicity.
CONCLUSION
• It is said that hyperinsulinemia therapy is beneficial
in patients with calcium channel blockers induced
hypotension , hyperglyceamia and acidosis.
• High dose insulin therapy and other standard
therapies discussed above are used in
combination.
• The prescribers should avoid these kind of
medication errors in order to improve patient safety.
REFERENCES
• Bronstein Ac, Spyker DA , Cantilena Jr ,Green JL,
Rumack BH,2008.
• Annual report of American association of poison
control centres
• National poison data system (26 th annual report).
• Spiller HA, milliner BA amlodipine poisoning in an
infant by J.Med toxicol 2012 ;8; 179-182
THANK YOU

More Related Content

What's hot

NSTEMI DrHafiz
NSTEMI DrHafizNSTEMI DrHafiz
NSTEMI DrHafiz
DrLinAli
 
Risk stratification and medical management of stemi
Risk stratification and medical management of stemiRisk stratification and medical management of stemi
Risk stratification and medical management of stemi
drranjithmp
 
Non st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable anginaNon st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable angina
Grerk Sutamtewagul
 

What's hot (20)

Wpw syndrome
Wpw syndromeWpw syndrome
Wpw syndrome
 
Acute myocardial infarction
Acute myocardial infarctionAcute myocardial infarction
Acute myocardial infarction
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Beta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseasesBeta-blockers in cardiovascular diseases
Beta-blockers in cardiovascular diseases
 
Acute MI - NSTEMI
Acute MI - NSTEMIAcute MI - NSTEMI
Acute MI - NSTEMI
 
ECG Changes in Myocardial Infarction
ECG Changes in Myocardial InfarctionECG Changes in Myocardial Infarction
ECG Changes in Myocardial Infarction
 
Management of Acute Coronary Syndrome
Management of Acute Coronary Syndrome Management of Acute Coronary Syndrome
Management of Acute Coronary Syndrome
 
Hypertension and stroke
Hypertension and stroke Hypertension and stroke
Hypertension and stroke
 
Wolff–Parkinson–White syndrome
Wolff–Parkinson–White syndromeWolff–Parkinson–White syndrome
Wolff–Parkinson–White syndrome
 
NSTEMI DrHafiz
NSTEMI DrHafizNSTEMI DrHafiz
NSTEMI DrHafiz
 
Antiplatelet therapy
Antiplatelet therapyAntiplatelet therapy
Antiplatelet therapy
 
Esc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronaryEsc 2020 guidelines for the management of acute coronary
Esc 2020 guidelines for the management of acute coronary
 
Management of Cardiogenic shock
Management of Cardiogenic shockManagement of Cardiogenic shock
Management of Cardiogenic shock
 
ATRIAL FIBRILLATION 2016
ATRIAL FIBRILLATION 2016ATRIAL FIBRILLATION 2016
ATRIAL FIBRILLATION 2016
 
Cardiorenal Syndrome
Cardiorenal SyndromeCardiorenal Syndrome
Cardiorenal Syndrome
 
Risk stratification and medical management of stemi
Risk stratification and medical management of stemiRisk stratification and medical management of stemi
Risk stratification and medical management of stemi
 
Acute coronary syndrome (acs)
Acute coronary syndrome (acs)Acute coronary syndrome (acs)
Acute coronary syndrome (acs)
 
Acute Coronary Syndrome - Overview
Acute Coronary Syndrome - OverviewAcute Coronary Syndrome - Overview
Acute Coronary Syndrome - Overview
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 
Non st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable anginaNon st elevation myocardial infarction and unstable angina
Non st elevation myocardial infarction and unstable angina
 

Viewers also liked

Amlodipine Benazepril Cost
Amlodipine Benazepril CostAmlodipine Benazepril Cost
Amlodipine Benazepril Cost
Amlodipine
 
Medication administration
Medication administrationMedication administration
Medication administration
Mohammad Aladam
 

Viewers also liked (20)

Calcium Channel Blockers
Calcium Channel BlockersCalcium Channel Blockers
Calcium Channel Blockers
 
calcium channel blockers
calcium channel blockerscalcium channel blockers
calcium channel blockers
 
Beta blockers
Beta blockers Beta blockers
Beta blockers
 
Beta blockers
Beta blockers Beta blockers
Beta blockers
 
Norvasc
NorvascNorvasc
Norvasc
 
Amlodipine Benazepril Cost
Amlodipine Benazepril CostAmlodipine Benazepril Cost
Amlodipine Benazepril Cost
 
Literature Survey & Market Survey on Amlodipine and its Recent Trends
Literature Survey & Market Survey on Amlodipine and its Recent TrendsLiterature Survey & Market Survey on Amlodipine and its Recent Trends
Literature Survey & Market Survey on Amlodipine and its Recent Trends
 
Beta1 selective blocker Metoprolol
Beta1 selective blocker MetoprololBeta1 selective blocker Metoprolol
Beta1 selective blocker Metoprolol
 
Generic Norvasc Tablets for Treatment of Hypertension and Angina Pectoris
Generic Norvasc Tablets for Treatment of Hypertension and Angina PectorisGeneric Norvasc Tablets for Treatment of Hypertension and Angina Pectoris
Generic Norvasc Tablets for Treatment of Hypertension and Angina Pectoris
 
Beta blockers in STEMI
Beta blockers in STEMIBeta blockers in STEMI
Beta blockers in STEMI
 
Calcium channel blockers
Calcium channel blockersCalcium channel blockers
Calcium channel blockers
 
Calcium channels –physiology and Therapeutics uses..
Calcium channels –physiology and Therapeutics uses..Calcium channels –physiology and Therapeutics uses..
Calcium channels –physiology and Therapeutics uses..
 
Calcium Channel Blockers
Calcium Channel Blockers Calcium Channel Blockers
Calcium Channel Blockers
 
Diuretics
DiureticsDiuretics
Diuretics
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Beta adrenergic blockers
Beta adrenergic blockersBeta adrenergic blockers
Beta adrenergic blockers
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
ANTI HYPERTENSIVE AGENTS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR, HYPERTENSION,...
 
Medication administration
Medication administrationMedication administration
Medication administration
 

Similar to Amlodipine poisoning

anaesthesia-for-endocrine-disease.pdf
anaesthesia-for-endocrine-disease.pdfanaesthesia-for-endocrine-disease.pdf
anaesthesia-for-endocrine-disease.pdf
YcelYce1
 
SBP (National Hepatic Institute)
SBP (National Hepatic Institute)SBP (National Hepatic Institute)
SBP (National Hepatic Institute)
Mohamed Moustafa
 

Similar to Amlodipine poisoning (20)

Anesthetic medications
Anesthetic medicationsAnesthetic medications
Anesthetic medications
 
SOAPping MI
SOAPping MISOAPping MI
SOAPping MI
 
LITERATURE SURVEY & MARKET SURVEY ON AMLODIPINE AND ITS RECENT TRENDS
LITERATURE SURVEY & MARKET SURVEY ON  AMLODIPINE AND ITS RECENT TRENDSLITERATURE SURVEY & MARKET SURVEY ON  AMLODIPINE AND ITS RECENT TRENDS
LITERATURE SURVEY & MARKET SURVEY ON AMLODIPINE AND ITS RECENT TRENDS
 
"UN"complicated hypertension
"UN"complicated hypertension "UN"complicated hypertension
"UN"complicated hypertension
 
Diabetes type 1
Diabetes type 1Diabetes type 1
Diabetes type 1
 
Lecture- 13. Congestive Cardiac Failure in Children
Lecture- 13. Congestive Cardiac Failure in ChildrenLecture- 13. Congestive Cardiac Failure in Children
Lecture- 13. Congestive Cardiac Failure in Children
 
Amlodipine :- Uses, Dosage, Side effects
Amlodipine :- Uses, Dosage, Side effectsAmlodipine :- Uses, Dosage, Side effects
Amlodipine :- Uses, Dosage, Side effects
 
anaesthesia-for-endocrine-disease.pdf
anaesthesia-for-endocrine-disease.pdfanaesthesia-for-endocrine-disease.pdf
anaesthesia-for-endocrine-disease.pdf
 
RECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptx
RECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptxRECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptx
RECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptx
 
RECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptx
RECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptxRECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptx
RECENT ADVANCES IN ANTI-DIABETIC THERAPY.pptx
 
case_discussion.pdf
case_discussion.pdfcase_discussion.pdf
case_discussion.pdf
 
Treatment of wilson disease
Treatment of wilson diseaseTreatment of wilson disease
Treatment of wilson disease
 
160465212 case-study-new-03
160465212 case-study-new-03160465212 case-study-new-03
160465212 case-study-new-03
 
Rational therapy of genetic disorder like diabetes mellitus
Rational therapy of genetic disorder like diabetes mellitusRational therapy of genetic disorder like diabetes mellitus
Rational therapy of genetic disorder like diabetes mellitus
 
Ppt b blockers presentation
Ppt b blockers presentationPpt b blockers presentation
Ppt b blockers presentation
 
Dka picu
Dka picuDka picu
Dka picu
 
SBP (National Hepatic Institute)
SBP (National Hepatic Institute)SBP (National Hepatic Institute)
SBP (National Hepatic Institute)
 
DM AND SURGERY.pptx
DM AND SURGERY.pptxDM AND SURGERY.pptx
DM AND SURGERY.pptx
 
drug poisoning
drug poisoningdrug poisoning
drug poisoning
 
Flunarazine
Flunarazine Flunarazine
Flunarazine
 

More from velspharmd

Pain management vels
Pain management velsPain management vels
Pain management vels
velspharmd
 
Anti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case StudyAnti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case Study
velspharmd
 
Thyroid function tests
Thyroid function testsThyroid function tests
Thyroid function tests
velspharmd
 

More from velspharmd (20)

Crossed Aldol Condensation
Crossed Aldol CondensationCrossed Aldol Condensation
Crossed Aldol Condensation
 
Anxiety Disorders
Anxiety DisordersAnxiety Disorders
Anxiety Disorders
 
Orchitis-Case Study
Orchitis-Case StudyOrchitis-Case Study
Orchitis-Case Study
 
simeprevir
simeprevirsimeprevir
simeprevir
 
Pain management vels
Pain management velsPain management vels
Pain management vels
 
Tivicay®
Tivicay®Tivicay®
Tivicay®
 
Anti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case StudyAnti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case Study
 
Nicotine addiction
Nicotine addictionNicotine addiction
Nicotine addiction
 
Thyroid function tests
Thyroid function testsThyroid function tests
Thyroid function tests
 
Role of atorvastatin
Role of atorvastatinRole of atorvastatin
Role of atorvastatin
 
Methyl alchohol poisoning
Methyl alchohol poisoningMethyl alchohol poisoning
Methyl alchohol poisoning
 
Renal function tests
Renal function testsRenal function tests
Renal function tests
 
Pulmonary function test
Pulmonary function testPulmonary function test
Pulmonary function test
 
Tests associated with cardiac disorders
Tests associated with cardiac disorders Tests associated with cardiac disorders
Tests associated with cardiac disorders
 
Thyroid function tests
Thyroid function testsThyroid function tests
Thyroid function tests
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
GASTROESOPHAGEAL REFLUX DISEASE
GASTROESOPHAGEAL REFLUX DISEASEGASTROESOPHAGEAL REFLUX DISEASE
GASTROESOPHAGEAL REFLUX DISEASE
 
ANXIETY DISORDERS
ANXIETY DISORDERSANXIETY DISORDERS
ANXIETY DISORDERS
 
INFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASEINFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASE
 
Food poisoning
Food poisoningFood poisoning
Food poisoning
 

Recently uploaded

Accounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdfAccounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdf
YibeltalNibretu
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 

Recently uploaded (20)

The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
NCERT Solutions Power Sharing Class 10 Notes pdf
NCERT Solutions Power Sharing Class 10 Notes pdfNCERT Solutions Power Sharing Class 10 Notes pdf
NCERT Solutions Power Sharing Class 10 Notes pdf
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx
 
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...Basic Civil Engineering Notes of Chapter-6,  Topic- Ecosystem, Biodiversity G...
Basic Civil Engineering Notes of Chapter-6, Topic- Ecosystem, Biodiversity G...
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Accounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdfAccounting and finance exit exam 2016 E.C.pdf
Accounting and finance exit exam 2016 E.C.pdf
 
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Benefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational ResourcesBenefits and Challenges of Using Open Educational Resources
Benefits and Challenges of Using Open Educational Resources
 
Forest and Wildlife Resources Class 10 Free Study Material PDF
Forest and Wildlife Resources Class 10 Free Study Material PDFForest and Wildlife Resources Class 10 Free Study Material PDF
Forest and Wildlife Resources Class 10 Free Study Material PDF
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
 
Solid waste management & Types of Basic civil Engineering notes by DJ Sir.pptx
Solid waste management & Types of Basic civil Engineering notes by DJ Sir.pptxSolid waste management & Types of Basic civil Engineering notes by DJ Sir.pptx
Solid waste management & Types of Basic civil Engineering notes by DJ Sir.pptx
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 

Amlodipine poisoning

  • 1. TOPIC: NEAR FATAL CASE OF AMLODIPINE POISONING IN AN INFANT INDIAN JOURNAL OF PEDIATRICS JUNE 2013 volume 80 by Somashekar M. Nimbalkar ,Dipen vasudev patel
  • 2. INTRODUCTION • Infants contribute about 5.25% of poisoning exposure. Only one case of amlodipine poisoning is reported in infants and the child recovered after treatment. • The authors report an 11 month old infant with nearly fatal amlodipine poisoning.
  • 3. CASE REPORT • A 11 month old infant received 6 doses of 15mg of amlodipine which was dispensed against prescribed amoxicillin for lower respiratory tract infection. • He presented with vomitting and reduced activity. • He worsened over few hours with increased lethargy, bradychardia, respiratory distress and progressive loss of consiousness , irregular heart sounds, bilateral creptations over chest and hepatomegaly.
  • 4. • His blood sugar was 382mg/dl. • On admission he had anemia. • Blood pressure remained at 70/40 mm Hg • He was progressed to hypotensive shock within three hours of admission.
  • 5. INVESTIGATION ADMISSION 24HOURS 48 HOURS 72 HOURS s.Creatinine(mg/dl) (0.6-1.5mg/dl) 0.59 0.81 0.49 0.34 s.Urea(8-25mg/dl) - 108 56 8 s.Sodium (135-148mmol/l) 129 124 131 146 s.Potassium (3.5-5.5 mmol/l) 5.8 5.7 3.6 21.9 s.Calcium(8-11mg/dl) 9.34 10.6 11.05 -
  • 6. INVESTIGATION ADMISSION 24 HRS 48 HRS 72 HRS Alanine transaminase (u/l) 44 - - 124 Aspartate transaminase(u/l) 112 - - 622 s.Total bilirubin(mg/dl) 0.24 - - 0.49 Haemoglobin(g/dl) 8.2 9.7 - HCO3(22-29 meq/l) 17 19.3 23.6 - PCO2(41-51mm hg) 33.4 34.6 34.6 - PO2(30-40 mm hg) 267 356.1 398.6 -
  • 7. • His blood sugar was found increased because Calcium channel blockers bind to alpha unit of L- type channel results in impaired secretion of insulin results in hyperglycemia. • CCB poisoning also results in insulin resistance. • The maximum therapeutic dose of amlodipine is 0.6mg/kg per day. But the 6kg infant received 15 mg three times a day. • Amlodipine three times a day for two days (about 12.5 times maximum dose of amlodipine).
  • 8. TREATMENT • He received mechanical ventilation. • Fluid therapy with normal saline was given. • His parameters only improved after giving insulin 0.5-1 unit/kg/hr was given for (15 hours) along with calcium gluconate infusion for (72 hours). • He was treated with adrenaline which is a powerful cardiac stimulant .It acts on beta receptors and increases heart rate, cardiac output.(as CCB in higher dose causes decrease in heart rate, decrease cardiac output)
  • 9. • Calcium channel blockers usually causes negative ionotropic effect ( weaken heart contraction and slows the heart rate). • So positive ionotropes such as dopamine, epinephrine are given to change the force of heart contractions and improves the heart rate. • To manage renal failure , oliguria(decrease in urine output), pulmonary edema, congestive cardiac failure peritoneal dialysis was initiated at 24 hours of admission and continued for 48 hours.
  • 10.  Child improved hence insulin infusion was tapered and stopped after 15 hours.  Ionotropes was tapered after 48 hours.  Calcium gluconate stopped after 72 hours.  Liver enzymes increased after 72 hours of ingestion without develpoment of jaundice.  Patient was discharged after 10 days .
  • 11. DISCUSSION • Calcium channel blockers are a potential source of risk for children due to the high dosage from strength ,in relation to the body weight. • A single dose of 10 mg nifedipine tablet was associated with the death of an infant. • Amlodipine has large volume of distribution and half life is 35-45 hours and overdose causes prolonged calcium channel blockers toxicity.
  • 12. • Animal studies have shown insulin improves myocardial infraction during shock induced by calcium channel blockers toxicity. • The author’s says that insulin therapy can be recommended as first line therapy for calcium channel blockers toxicity.
  • 13. CONCLUSION • It is said that hyperinsulinemia therapy is beneficial in patients with calcium channel blockers induced hypotension , hyperglyceamia and acidosis. • High dose insulin therapy and other standard therapies discussed above are used in combination. • The prescribers should avoid these kind of medication errors in order to improve patient safety.
  • 14. REFERENCES • Bronstein Ac, Spyker DA , Cantilena Jr ,Green JL, Rumack BH,2008. • Annual report of American association of poison control centres • National poison data system (26 th annual report). • Spiller HA, milliner BA amlodipine poisoning in an infant by J.Med toxicol 2012 ;8; 179-182